MedPlus Health Services Limited

Material Risks

AI Risk Summary

**Financial Risk Summary: MedPlus Health Services Limited** MedPlus faces severe compliance risk (10.0/10 score) with estimated remediation costs of ₹108–404 crore under SEBI BRSR Core Expansion and extended producer responsibility (EPR) obligations, representing 0.16–0.60% of annual revenue. The company's unknown EPR applicability status (6.5/10 exposure) creates immediate regulatory uncertainty—pharmaceutical and medical goods typically trigger EPR liability under India's Plastic Waste Management Rules 2021, requiring extended producer responsibility infrastructure investments and potential penalty exposure up to ₹50 lakh per violation. Non-compliance with mandatory BRSR disclosures on Scope 1/2 emissions (currently reported as none) risks SEBI enforcement action and delisting for a top-tier listed entity, while missing environmental baseline data prevents accurate carbon pricing exposure assessment under the proposed India Carbon Credit Trading Scheme (₹600–900/tonne). Immediate priority: clarify EPR classification, establish emissions baseline data, and align disclosure frameworks to avoid regulatory penalties and market credibility erosion.

Source: MedPlus Health Services Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.